Please login to the form below

Breast Cancer Now

This page shows the latest Breast Cancer Now news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Tecentriq set for breast cancer filing, Ocrevus gets NICE thumbs down, NHS needs more cash

Daily Brief: Tecentriq set for breast cancer filing, Ocrevus gets NICE thumbs down, NHS needs more cash. ... Checkpoint inhibitor immunotherapy drugs have targeted other tumour types before turning to breast cancer, but now Roche's Tecentriq looks set to

Latest news

Daily Brief: Amgen offers Repatha deals in Europe, will Persephone slash Herceptin use?

Baroness Delyth Morgan, Chief Executive at UK charity Breast Cancer Now (pictured) said: “This marks a really promising step towards being able to safely offer patients a much shorter course of ... Herceptin remains one of the most important advances
NICE backs two advanced breast cancer drugs after price cuts

Women in England and Wales with advanced breast cancer can now get access to two CDK 4/6 inhibitor drugs - Pfizer’s Ibrance and Novartis’Kisqali - after pricing negotiations between the ... important breakthroughs for women with advanced breast
Dismay as NICE turns down first-line use of AZ's Faslodex

AstraZeneca's hopes of expanding the use of its breast cancer therapy Faslodex in the UK look rocky after NICE rejected the drug in draft guidance. ... Baroness Delyth Morgan, chief executive at medical charity Breast Cancer Now, said the verdict was
Novartis claims EU approval for breast cancer drug Kisqali

Novartis claims EU approval for breast cancer drug Kisqali. Firm's CDK4/6 inhibitor can now challenge Pfizer's Ibrance in Europe. ... Novartis can now challenge Pfizer's blockbuster breast cancer drug Ibrance in Europe after gaining approval for its
Clovis rockets on maintenance data in ovarian cancer

their indications into other indications such as breast cancer. ... Another candidate - AbbVie's veliparib - failed two phase III trials in April (in breast and lung cancer) and now looks unlikely to challenge the leaders.

More from news
Approximately 2 fully matching, plus 32 partially matching documents found.

Latest Intelligence

30 women leaders in UK healthcare (part 3)

28. Baroness Delyth Morgan, Breast Cancer Now Chief Executive. Delyth has been a central figure in breast cancer charities for more than 20 years, building the sector’s voice in health ... In 2015 she oversaw the merger of her organisation Breast
Engaging the digital healthcare professional

Two days after the student midwife’s tweet, UK organisation Breast Cancer Now shared its own response to the guidance, also tweeting to Pfizer and NICE and urging them to work ... Breast Cancer Now is followed by almost 40, 000, and its tweet, which it

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Graduate Scientific Editor: DOE

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Sudler London - Account Director: Competitive

Medical Writers Required - Hertfordshire: Competitive

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Systematic Review Lead- London: Negotiable

Senior Training Manager - Surrey: Competitive Salary &Bonus

Account Manager: Negotiable

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Market Access Consultant - Greater Manchester: Negotiable

Account Manager- 4 days per week or full-time: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Medical Writer, MedComms Agency: Salary TBC

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Senior Medical Writer: Salary is DOE

Senior Account Manager – Healthcare Advertising: Salary TBC

Healthcare PR Senior Account Manager: Salary TBC

Associate Scientific Director: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Medical Writer - Creative and Scientific Projects: DOE

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....